An unexpected mechanism regulates the immune response during parasitic infections
Researchers at the University of Liège (Belgium) have uncovered a previously unknown mechanism that regulates the immune ...
Microglia reprogramming offers novel strategy to combat melanoma brain metastases
Brain metastases are one of the most severe complications of melanoma, the most aggressive type of skin cancer. Researchers ...
Doctor slams myths on five 'immunity' foods including garlic misconception
Use precise geolocation data and actively scan device characteristics for identification. This is done to store and access ...
Where Will Iovance Biotherapeutics Be in 5 Years?
Iovance Biotherapeutics (NASDAQ: IOVA), a small-cap biotech company, has an innovative approach to treating cancer that relies on harnessing patients' cancer-fighting capabilities. Iovance's shares ...
Hosted on MSN15d
Researchers pinpoint keys to cell therapy response for leukemia
DLI is a follow-on treatment that can help stave off or treat relapse. It involves an infusion of white blood cells, called lymphocytes, from the donor of the stem cell transplant into the patient.
News Medical16d
Researchers identify key factors for successful donor lymphocyte infusion in AML patients
DLI is a follow-on treatment that can help stave off or treat relapse. It involves an infusion of white blood cells, called lymphocytes, from the donor of the stem cell transplant into the patient.
Frontiers1mon
Generation and characterization of OX40-ligand fusion protein that agonizes OX40 on T-Lymphocytes
1 Laboratory of Molecular Cell Biology, Graduate School of Medicine and Pharmaceutical Sciences, University of Toyama, Toyama, Japan 2 Department of Microbiology and Immunology, Tohoku University ...
ki.se2y
Clinical Lung and Allergy Research Unit (CLARU)
At the Clinical Lung and Allergy Research Unit (CLARU), we perform internationally leading clinical and translational lung and allergy research to the benefit of patients. The Clinical Lung- and ...